Award · Healthcare & Life Sciences

BioCipher Labs wins HealthSprint 2026 medtech programme

By Startup Enthusiast · 29 August 2026

What they do

BioCipher Labs is a Bengaluru-based startup that develops AI-powered molecular diagnostics for infectious diseases

The company won the HealthSprint 2026 programme alongside Prodancy and Mykare.ai, securing an immersive week-long trip to Israel

The programme focuses on clinical validation and scaling, with winners gaining access to the Israeli healthcare and innovation ecosystem

BioCipher Labs was named a winner of the HealthSprint 2026 medtech startup programme.
The startup shares this recognition with Prodancy and Mykare.ai.
Winners receive a fully funded week-long immersive programme in Israel.
The trip allows startups to engage with the local healthcare and innovation ecosystem.
Participants will explore global market validation and strategies for scaling their businesses.
The programme received 175 applications in total.
Organisers shortlisted 15 startups across three categories: Diagnose, Treat, and Manage.

The programme prioritised clinical validation and the achievement of fundable milestones.
Mentors and investors from Israel included representatives from Sheba Medical Centre and eHealth Ventures.
The selection process evaluated the ability of founders to learn from failure and adapt their business models.

BioCipher Labs operates as an advanced biotechnology and molecular diagnostics laboratory.
The company focuses primarily on the diagnosis of infectious diseases.
It utilizes technologies including PCR, RT-PCR, Next-Generation Sequencing, and CRISPR-based diagnostics.
The firm integrates AI-driven algorithms to perform real-time analysis of molecular biology and genomics data.
Operations currently span seven states including Karnataka, Maharashtra, and Tamil Nadu.
Prodancy developed an indigenous surgical helmet for joint replacement surgeries.
Mykare.ai provides an AI-native patient management platform for smaller hospitals and clinics.